Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Norman Gitlin"'
Autor:
A. Sidney Barritt, Stephanie Watkins, Norman Gitlin, Samuel Klein, Anna S. Lok, Rohit Loomba, Cheryl Schoen, K. Rajender Reddy, Huy Ngoc Trinh, Andrea R. Mospan, Miriam B. Vos, L. Michael Weiss, Kenneth Cusi, Brent A. Neuschwander‐Tetri, Arun J. Sanyal
Publikováno v:
Hepatology Communications, Vol 5, Iss 6, Pp 938-946 (2021)
Much of the current data on nonalcoholic fatty liver disease (NAFLD) are derived from biopsy‐based studies that may introduce ascertainment and selection bias. Selection of patients for liver biopsy has implications for clinical practice and the re
Externí odkaz:
https://doaj.org/article/cd7644ce825744c5998578481955510e
Autor:
Arun J. Sanyal, Miriam B. Vos, Cheryl Schoen, L. Michael Weiss, Norman Gitlin, Andrea R. Mospan, Samuel Klein, Rohit Loomba, Kenneth Cusi, Huy N. Trinh, K. Rajender Reddy, Brent A. Neuschwander-Tetri, Stephanie Watkins, Anna S. Lok, A. Sidney Barritt
Publikováno v:
Hepatology Communications, Vol 5, Iss 6, Pp 938-946 (2021)
Hepatology Communications
Hepatology Communications
Much of the current data on nonalcoholic fatty liver disease (NAFLD) are derived from biopsy‐based studies that may introduce ascertainment and selection bias. Selection of patients for liver biopsy has implications for clinical practice and the re
Autor:
L. Michael Weiss, Alfred S. Barritt, Laura Malahias, Brent A. Neuschwander-Tetri, Miriam B. Vos, Margaret Powell, Norman Gitlin, Kenneth Cusi, Anna S. Lok, Arun J. Sanyal, Rohit Loomba, Samuel Klein
Publikováno v:
Contemporary Clinical Trials. 61:33-38
Nonalcoholic fatty liver disease (NAFLD) is highly prevalent and can lead to cirrhosis, hepatocellular carcinoma, and end-stage liver disease. NAFLD comprises the spectrum from simple steatosis (nonalcoholic fatty liver, NAFL), to steatosis with infl
Autor:
Robert L. Martin, Gideon M. Hirschfield, Mitchell L. Shiffman, Ewa Janczewska, Mark Jonas, Linsey Corless, Joseph A. Odin, Alexandra Steinberg, Virginia Clark, Yvonne Doerffel, David Sheridan, Norman Gitlin, Pol Boudes, Marek Hartleb, David E. Bernstein, M Varga, Peter Buggisch, Harinder Chera, Heinz Hartmann, Stuart C. Gordon, Cynthia Levy, Yun-Jung Choi, Markus Alexander Wörns, Bruce R Bacon, John M. Vierling, Christopher L. Bowlus, Mark G. Swain, Mcwherter Charles A, Michael R Galambos, Bradley Freilich, David Jones, George F. Mells, Hemant Shah, Andreas E. Kremer, Fedja A. Rochling, John H. Smith
Publikováno v:
The Lancet Gastroenterology & Hepatology. 2:716-726
Summary Background Many patients with primary biliary cholangitis have an inadequate response to first-line therapy with ursodeoxycholic acid. Seladelpar is a potent, selective agonist for the peroxisome proliferator-activated receptor-delta (PPAR-δ
Autor:
Zobair M Younossi, Vlad Ratziu, Rohit Loomba, Mary Rinella, Quentin M Anstee, Zachary Goodman, Pierre Bedossa, Andreas Geier, Susanne Beckebaum, Philip N Newsome, David Sheridan, Muhammad Y Sheikh, James Trotter, Whitfield Knapple, Eric Lawitz, Manal F Abdelmalek, Kris V Kowdley, Aldo J Montano-Loza, Jerome Boursier, Philippe Mathurin, Elisabetta Bugianesi, Giuseppe Mazzella, Antonio Olveira, Helena Cortez-Pinto, Isabel Graupera, David Orr, Lise Lotte Gluud, Jean-Francois Dufour, David Shapiro, Jason Campagna, Luna Zaru, Leigh MacConell, Reshma Shringarpure, Stephen Harrison, Arun J Sanyal, Manal Abdelmalek, Gary Abrams, Humberto Aguilar, Aijaz Ahmed, Elmar Aigner, Guruprasad Aithal, Aftab Ala, William Alazawi, Agustin Albillos, Michael Allison, Sfa Al-Shamma, Raul Andrade, Pietro Andreone, Mario Angelico, Victor Ankoma-Sey, Quentin Anstee, Rodolphe Anty, Victor Araya, Juan Ignacio Arenas Ruiz, Perttu Arkkila, Marty Arora, Tarik Asselah, Jennifer Au, Oyekoya Ayonrinde, Robert James Bailey, Maya Balakrishnan, Kiran Bambha, Meena Bansal, Sidney Barritt, John Bate, Jorge Beato, Jaideep Behari, Pablo Bellot, Ziv Ben Ari, Michael Bennett, Marina Berenguer, Benedetta Terziroli Beretta-Piccoli, Thomas Berg, Maurizio Bonacini, Lucia Bonet, Brian Borg, Marc Bourliere, William Bowman, David Bradley, Marija Brankovic, Marius Braun, Jean-Pierre Bronowicki, Savino Bruno, Cindy Cai, Amy Calderon, José Luis Calleja Panero, Elizabeth Carey, Michal Carmiel, Jose Antonio Carrión, Matthew Cave, Cristina Chagas, Tawfik Chami, Alan Chang, Allan Coates, Jeremy Cobbold, Charlote Costentin, Kathleen Corey, Lynsey Corless, Javier Crespo, Oscar Cruz Pereira, Victor de Ledinghen, Andrew deLemos, Moises Diago, Mamie Dong, Jean-François Dufour, Predrag Dugalic, Winston Dunn, Magby Elkhashab, Michael Epstein, Maria Desamparados Escudero-Garcia, Ohad Etzion, Larry Evans, Robert Falcone, Conrado Fernandez, Jose Ferreira, Scott Fink, Kevin Finnegan, Roberto Firpi-Morell, Annarosa Floreani, Thierry Fontanges, Ryan Ford, Ewan Forrest, Andrew Fowell, Anna Ludovica Fracanzani, Sven Francque, Bradley Freilich, Juan Frias, Michael Fuchs, Javier Fuentes, Michael Galambos, Juan Gallegos, Anja Geerts, Jacob George, Maged Ghali, Reem Ghalib, Pierre Gholam, Pere Gines, Norman Gitlin, Tobias Goeser, John Goff, Stuart Gordon, Frederic Gordon, Odile Goria, Shaun Greer, Alla Grigorian, Henning Gronbaek, Maeva Guillaume, Naresh Gunaratnam, Dina Halegoua-De Marzio, Bilal Hameed, Stephanie Hametner, James Hamilton, Marek Hartleb, Tarek Hassanein, Dieter Häussinger, Paul Hellstern, Robert Herring, Eva Heurich, Christophe Hezode, Holger Hinrichsen, Peter Holland Fischer, Yves Horsmans, Jonathan Huang, Hyder Hussaini, Antoine Jakiche, Lennox Jeffers, Blake Jones, Rosa Jorge, Francisco Jorquera, Shoba Joshi, Alisan Kahraman, Kelly Kaita, Nicholas Karyotakis, Zeid Kayali, Stergios Kechagias, Thomas Kepczyk, Mandana Khalili, Hicham Khallafi, Johannes Kluwe, Anita Kohli, Kevin Korenblat, Kris Kowdley, Aleksander Krag, Richard Krause, Andreas Kremer, Karen Krok, Miodrag Krstic, Marcelo Kugelmas, Sonal Kumar, Scott Kuwada, Damien Labarriere, Michelle Lai, Wim Laleman, Pietro Lampertico, Alice Lee, Vincent Leroy, Steven Lidofsky, Tina Huey Lim, Joseph Lim, Donald Lipkis, Ester Little, Amadeo Lonardo, Michelle Long, Velimir Anthony Christopher Luketic, Yoav Lurie, Guilherme Macedo, Joana Magalhaes, Mihály Makara, Benedict Maliakkal, Michael Manns, Pinelopi Manousou, Parvez Mantry, Giulio Marchesini, Carla Marinho, Paul Marotta, Hanns-Ulrich Marschall, Linda Martinez, Marlyn Mayo, Mark McCullen, William McLaughlin, Uta Merle, Raphael Merriman, Apurva Modi, Esther Molina, Aldo Montano-Loza, Carlos Monteverde, Amilcar Morales Cardona, Sulleman Moreea, Christophe Moreno, Filomena Morisco, Abdullah Mubarak, Beat Muellhaupt, Sandeep Mukherjee, Tobias Müller, Aleksandar Nagorni, Jahnavi Naik, Guy Neff, Moises Nevah, Philip Newsome, Eric Nguyen-Khac, Mazen Noureddin, Jude Oben, Hans Orlent, James Orr, Grisell Ortiz-Lasanta, Violaine Ozenne, Prashant Pandya, Angelo Paredes, James Park, Joykumar Patel, Keyur Patel, Sonali Paul, Heather Patton, Markus Peck-Radosavljevic, Salvatore Petta, Stephen Pianko, Anna Piekarska, Neville Pimstone, Joseph Pisegna, Paul Pockros, Stanislas Pol, Michael Porayko, John Poulos, David Pound, Joe Pouzar, Jose Presa Ramos, Nikolaos Pyrsopoulos, Nila Rafiq, Kate Muller, Alnoor Ramji, Ravi Ravinuthala, Chakradhar Reddy, Gautham Reddy K G, K. Rajender Reddy K R, Frederic Regenstein, Robert Reindollar, Justin Reynolds, Andres Riera, Jose Rivera Acosta, Geert Robaeys, Stuart Roberts, Federico Rodriguez-Perez, Sandor Romero, Manuel Romero-Gomez, Raymond Rubin, Mariagrazia Rumi, Simon Rushbrook, Christian Rust, Michael Ryan, Rifaat Safadi, Adnan Said, Kimmo Salminen, Didier Samuel, John Santoro, Arun Sanyal, Souvik Sarkar, Cynthia Schaeffer, Jörn Schattenberg, Ingolf Schiefke, Eugene Schiff, Wolfgang Schmidt, Jeffrey Schneider, Jeoffrey Schouten, Michael Schultz, Giada Sebastiani, David Semela, Thomas Sepe, Aasim Sheikh, Muhammad Sheikh, Kenneth Sherman, Oren Shibolet, Mitchell Shiffman, Asma Siddique, Cyril Sieberhagen, Samuel Sigal, Katarzyna Sikorska, Krzysztof Simon, Marie Sinclair, Richard Skoien, Joel Solis, Siddharth Sood, Bob Souder, James Spivey, Per Stal, Laura Stinton, Simone Strasser, Petar Svorcan, Gyongzi Szabo, Andrew Talal, Edward Tam, Brent Tetri, Paul Thuluvath, Hillel Tobias, Krzysztof Tomasiewicz, Dawn Torres, Albert Tran, Michael Trauner, Christian Trautwein, Emanuel Tsochatzis, Esther Unitt, Victor Vargas, Istvan Varkonyi, Ella Veitsman, Umberto Vespasiani Gentilucci, David Victor, John Vierling, Catherine Vincent, Aron Vincze, Manfred von der Ohe, Natasha Von Roenn, Raj Vuppalanchi, Michael Waters, Kymberly Watt, Julia Wattacheril, Martin Weltman, Amanda Wieland, Gregory Wiener, Alonzo Williams A, Jeffrey Williams J, Jason Wilson, Maria Yataco, Eric Yoshida, Ziad Younes, Liyun Yuan, Adam Zivony, Donald Zogg, Heinz Zoller, Fabien Zoulim, Eli Zuckerman, Massimo Zuin
Publikováno v:
REGENERATE Study Investigators 2019, ' Obeticholic acid for the treatment of non-alcoholic steatohepatitis : interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ', The Lancet, vol. 394, no. 10215, pp. 2184-2196 . https://doi.org/10.1016/S0140-6736(19)33041-7
The lancet : international edition
Younossi, Z M, Ratziu, V, Loomba, R, Rinella, M, Anstee, Q M, Goodman, Z, Bedossa, P, Geier, A, Beckebaum, S, Newsome, P N, Sheridan, D, Sheikh, M Y, Trotter, J, Knapple, W, Lawitz, E, Abdelmalek, M F, Kowdley, K V, Montano-Loza, A J, Boursier, J, Mathurin, P, Bugianesi, E, Mazzella, G, Olveira, A, Cortez-Pinto, H, Graupera, I, Orr, D, Gluud, L L, Dufour, J-F, Shapiro, D, Campagna, J, Zaru, L, MacConell, L, Shringarpure, R, Harrison, S, Sanyal, A J & REGENERATE Study Investigators 2019, ' Obeticholic acid for the treatment of non-alcoholic steatohepatitis : interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ', The Lancet, vol. 394, no. 10215, pp. 2184-2196 . https://doi.org/10.1016/S0140-6736(19)33041-7
The lancet : international edition
Younossi, Z M, Ratziu, V, Loomba, R, Rinella, M, Anstee, Q M, Goodman, Z, Bedossa, P, Geier, A, Beckebaum, S, Newsome, P N, Sheridan, D, Sheikh, M Y, Trotter, J, Knapple, W, Lawitz, E, Abdelmalek, M F, Kowdley, K V, Montano-Loza, A J, Boursier, J, Mathurin, P, Bugianesi, E, Mazzella, G, Olveira, A, Cortez-Pinto, H, Graupera, I, Orr, D, Gluud, L L, Dufour, J-F, Shapiro, D, Campagna, J, Zaru, L, MacConell, L, Shringarpure, R, Harrison, S, Sanyal, A J & REGENERATE Study Investigators 2019, ' Obeticholic acid for the treatment of non-alcoholic steatohepatitis : interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ', The Lancet, vol. 394, no. 10215, pp. 2184-2196 . https://doi.org/10.1016/S0140-6736(19)33041-7
© 2019 Elsevier Ltd. All rights reserved.
Background: Non-alcoholic steatohepatitis (NASH) is a common type of chronic liver disease that can lead to cirrhosis. Obeticholic acid, a farnesoid X receptor agonist, has been shown to improve the his
Background: Non-alcoholic steatohepatitis (NASH) is a common type of chronic liver disease that can lead to cirrhosis. Obeticholic acid, a farnesoid X receptor agonist, has been shown to improve the his
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7b4774824d4fc96584556df1079fe77
Autor:
Aasim Sheikh, David R. Nelson, Mordechai Rabinovitz, Asma Siddique, Natarajan Ravendhran, Norman Gitlin, Rafia Bhore, Jacob Lalezari, Gary Poleynard, Stephanie Noviello, Terry Box, Khurram Rana, Kris V. Kowdley
Publikováno v:
Liver International. 36:1611-1618
Background and aims Many currently available direct-acting antiviral (DAA) regimens are less effective against HCV genotype 3 than against other HCV genotypes. The all-oral, pangenotypic DAA combination of daclatasvir (NS5A inhibitor) + sofosbuvir (n
Autor:
David E. Bernstein, Bart Fevery, Paul Y. Kwo, Eugene R. Schiff, Rekha Sinha, M. Davis, Ronald Nahass, Jane Scott, Norman Gitlin, James Witek, R. Kalmeijer, Monika Peeters, Sergio Rojter, Peter Ruane, Guy De La Rosa, K.P. Etzkorn, Oliver Lenz, Ziad Younes
Publikováno v:
Hepatology (Baltimore, Md.)
Effective antiviral therapy is essential for achieving sustained virological response (SVR) in hepatitis C virus (HCV)-infected patients. The phase 2 COSMOS study reported high SVR rates in treatment-naive and prior null-responder HCV genotype (GT) 1
Autor:
Mark S. Sulkowski, Mitchell L. Shiffman, Nezam H. Afdhal, Natarajan Ravendhran, Norman Gitlin, Kris V. Kowdley, Yanni Zhu, Jenny C. Yang, Kimberly A. Workowski, Julius M. Wilder, Charles D. Howell, Phillip S. Pang, John G. McHutchison, Andrew J. Muir, Lennox J. Jeffers, John E. Poulos, K. Rajender Reddy
Publikováno v:
Hepatology (Baltimore, Md.)
Black patients chronically infected with genotype 1 hepatitis C virus (HCV) have historically had lower rates of response to interferon‐based treatment than patients of other races. In the phase 3 ION program, the single‐tablet regimen of the NS5
Autor:
K. Sims, Shu-Pang Huang, James M. Levin, David F. Gardiner, Vinod K. Rustgi, Tarek Hassanein, Zobair M. Younossi, Federico Hinestrosa, Gregory T. Everson, Trevor Hawkins, Norman Gitlin, Maribel Rodriguez-Torres, Howard J. Schwartz, Timothy Eley, Tadesse Desta, Dennis M. Grasela, Lynn R. Webster, Fiona McPhee, Paul J. Thuluvath, Eric Lawitz
Publikováno v:
Liver International. 36:189-197
Background and Aims This phase-2b study examined the safety and efficacy of an all-oral, interferon-free combination of the NS5A replication complex inhibitor daclatasvir (DCV), the NS3 protease inhibitor asunaprevir (ASV), and the nonnucleoside NS5B
Autor:
James N. Cooper, Ziad Younes, Reem Ghalib, Grisell Ortiz-Lasanta, Trevor Hawkins, Norman Gitlin, Jacob Lalezari, Fiona McPhee, David E. Bernstein, Paul J. Pockros, Delphine Hennicken, William Harlan, Eric Hughes, Khurram Rana, Natarajan Ravendhran, Paul J. Thuluvath, Eric Lawitz, Peter Varunok, David R. Nelson, Kris V. Kowdley, Mordechai Rabinovitz, B. Freilich, Aasim Sheikh, Godson Oguchi, Michael J. Bennett
Publikováno v:
Hepatology (Baltimore, Md.)
Chronic infection with hepatitis C virus (HCV) genotype 3 is common throughout the world and remains a significant disease burden for many patients.1,2 Infection with HCV genotype 3 has been associated with an increased risk of progression to cirrhos